Miri joined as CEO of Joy Ventures in January 2018. Prior to Joy, Miri co-founded and led Israel Brain Technologies (IBT), a non-profit envisioned by late Israeli President Shimon Peres that accelerated brain-related innovation and established Israel as a global brain technology hub. Miri started her business career as a corporate economist at Teva Pharmaceuticals and later held financial management positions at Pfizer in New York. She also served as VP Finance at IntegraMed, a specialty healthcare services firm. Miri holds a Bachelor of Arts in Economics and Mathematics and a Master of Arts in Health Economics, from Boston University, as well as an MBA from New York University Stern School of Business.